Scarica l'app Stockscreener
236.37
1.60%
3.72
Pre-mercato:
233.77
-2.60
-1.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LH Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$232.65
Aprire:
$233.19
Volume 24 ore:
776.74K
Relative Volume:
1.35
Capitalizzazione di mercato:
$19.47B
Reddito:
$12.71B
Utile/perdita netta:
$435.50M
Rapporto P/E:
45.90
EPS:
5.15
Flusso di cassa netto:
$843.20M
1 W Prestazione:
+1.30%
1M Prestazione:
-5.84%
6M Prestazione:
+7.93%
1 anno Prestazione:
+11.52%
Intervallo 1D:
$231.65
$237.30
Intervallo di 1 settimana:
$228.11
$237.30
Portata 52W:
$191.97
$258.59
Labcorp Holdings Inc Stock (LH) Company Profile
Nome
Labcorp Holdings Inc
Settore
Industria
Telefono
(336) 229-1127
Indirizzo
358 S MAIN ST, BURLINGTON, NC
Confronta LH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
236.37 | 19.47B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
489.06 | 182.21B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.16 | 143.37B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
426.25 | 33.92B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
115.99 | 33.08B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
174.37 | 30.19B | 15.41B | 1.37B | 2.11B | 7.50 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Ripresa | Jefferies | Buy |
| 2024-10-30 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-10-01 | Iniziato | Piper Sandler | Neutral |
| 2024-03-25 | Aggiornamento | Argus | Hold → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Iniziato | Evercore ISI | In-line |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-09-19 | Downgrade | Argus | Buy → Hold |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-01-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Aggiornamento | Argus | Hold → Buy |
| 2021-01-11 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-13 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Ripresa | Deutsche Bank | Buy |
| 2020-05-15 | Aggiornamento | Mizuho | Neutral → Buy |
| 2020-04-29 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-04-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2019-07-16 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2019-01-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-30 | Downgrade | Argus | Buy → Hold |
| 2018-10-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Ripresa | BofA/Merrill | Buy |
| 2018-06-07 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Iniziato | Argus | Buy |
Mostra tutto
Labcorp Holdings Inc Borsa (LH) Ultime notizie
Assessing Labcorp Hldgs: Insights From 8 Financial Analysts - Benzinga
Labcorp Launches New Blood Test to Diagnose Alzheimer's Disease - MarketScreener
LH Stock to Gain From Launch of HPV and STI Self-Collection Options - TradingView
Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease - Seeking Alpha
Redburn Atlantic Initiates Labcorp Holdings at Buy With $276 Price Target - MarketScreener
Esoteric Testing Market Deep Research 2025-2032 | LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings - openPR.com
Labcorp Launches First-Of-Its-Kind Immunoassay To Accelerate Path To Diagnosis Of Alzheimer's Disease - MarketScreener
Labcorp Holdings (NYSE:LH) Introduces FDA-Approved Self-Collection Tests For HPV And STIs - Yahoo Finance
Labcorp to Announce First Quarter Financial Results on April 29, 2025 - Eastern Progress
Labcorp to offer HPV and STI self-collection solutions - TipRanks
Game-Changing HPV Testing: Labcorp Rolls Out Private Self-Collection Options Nationwide - Stock Titan
Labcorp Holdings to Announce Q1 2025 Financial Results - TipRanks
Labcorp Earnings Preview: Q1 2025 Results Coming April 29Key Updates Expected - Stock Titan
LabCorp EVP Mark Schroeder sells $610,450 in stock By Investing.com - Investing.com South Africa
Labcorp holdings EVP Amy Summy sells $175,605 in stock - Investing.com
LabCorp EVP Mark Schroeder sells $610,450 in stock - Investing.com
Baird Adjusts Labcorp Holdings Price Target to $292 From $293, Maintains Outperform Rating - MarketScreener
Labcorp 401(k) Plan Fee Class Action Gets Green Light for Trial - news.bloombergtax.com
Labcorp Denied Early Win In 401(k) Fee Suit - Law360
Is Labcorp Holdings Stock Outperforming the Nasdaq? - MSN
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack - Yahoo Finance
Labcorp to close Los Angeles site, lay off 73 people - Yahoo Finance
Why Labcorp (LH) is a Top Growth Stock for the Long-Term - Yahoo Finance
Labcorp Holdings Inc. (NYSE:LH) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed? - simplywall.st
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio - Yahoo Finance
Labcorp is Set to Acquire Select Assets of BioReference Health of OPK - Yahoo Finance
Labcorp Warns Fed. Circ. Of 'Balkanization' In Prenatal IP Row - Law360
Labcorp’s SWOT analysis: clinical testing giant’s stock faces growth opportunities - Investing.com
Labcorp to acquire certain assets of Opko Health’s BioReference Health - Yahoo Finance
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’ - Yahoo Finance
Labcorp to buy Opko unit’s cancer test assets for up to $225M - Yahoo Finance
Labcorp to acquire BioReference Health assets for up to $225M By Investing.com - Investing.com Canada
Truist maintains Buy on LabCorp stock, keeps $285 target By Investing.com - Investing.com Canada
Opko Health Sells BioReference Assets to Labcorp - TipRanks
Labcorp Announces Acquisition Of Select Assets Of Bioreference Health's Innovative Oncology And Related Clinical Testing Services Businesses - Marketscreener.com
Labcorp to buy certain assets of OPKO unit BioReference Health - MSN
Labcorp stock gains on deal to buy OPKO assets (LH:NYSE) - Seeking Alpha
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million - MarketWatch
Labcorp To Buy Certain Assets Of BioReference Health For A Maximum $225 Mln - Nasdaq
Labcorp's $225M Oncology Testing Expansion: Strategic BioReference Assets Acquisition Promises Market Growth - StockTitan
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Labcorp Holdings' (NYSE:LH) Strong Earnings Are Of Good Quality - Yahoo Finance
Labcorp director Anderson sells shares for $127,817 By Investing.com - Investing.com Australia
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN
Labcorp director Anderson sells shares for $127,817 - Investing.com
Should Labcorp Stock Stay In Your Portfolio Right Now? - Barchart
Should Labcorp Stock Stay in Your Portfolio Right Now? - Nasdaq
Labcorp Faces Mixed Investor Reactions Amid Market FluctuationsNews and Statistics - IndexBox, Inc.
Citigroup Upgrades Labcorp Holdings (LH) - MSN
Labcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment Mixed - MSN
Labcorp Holdings Inc Azioni (LH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.81%
0.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):